Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization
- DOI
- 10.3389/fphar.2026.1941296
- Published
- 2026-09-09
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1941296,
title = {Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization},
author = {Yuhan Tang and Shaochun Liu and Yingze Zhu and Linlin Fan and Xiaoxi Han and Wenjie Ma and Haolu Zhang and Zhiqi Sui and Hui Pang and Wenhui Zhao},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1941296},
url = {https://doi.org/10.3389/fphar.2026.1941296}
}RIS
TY - JOUR TI - Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization AU - Yuhan Tang AU - Shaochun Liu AU - Yingze Zhu AU - Linlin Fan AU - Xiaoxi Han AU - Wenjie Ma AU - Haolu Zhang AU - Zhiqi Sui AU - Hui Pang AU - Wenhui Zhao PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1941296 UR - https://doi.org/10.3389/fphar.2026.1941296 ER -
APA
Tang, Y., Liu, S., Zhu, Y., Fan, L., Han, X., Ma, W., Zhang, H., Sui, Z., Pang, H., & Zhao, W. (2026). Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1941296
Source records
- crossref · retrieved 2026-09-25T01:58:05.860Z